Chinese Journal of Tissue Engineering Research ›› 2022, Vol. 26 ›› Issue (29): 4699-4703.doi: 10.12307/2022.908

Previous Articles     Next Articles

Mechanism by which SC79, an Akt activator, inhibits dexamethasone-induced apoptosis and programmed necrosis of osteoblasts

Song Jianzhi, Xu Lisen, Zhang Chen, Tu Feng, Niu Fei   

  1. Department of Orthopaedics, Wuhan First Hospital (Wuhan Hospital of Integrated Traditional Chinese and Western Medicine), Wuhan 430022, Hubei Province, China
  • Received:2021-09-28 Accepted:2021-12-01 Online:2022-10-18 Published:2022-03-26
  • Contact: Song Jianzhi, Department of Orthopaedics, Wuhan First Hospital (Wuhan Hospital of Integrated Traditional Chinese and Western Medicine), Wuhan 430022, Hubei Province, China
  • About author:Song Jianzhi, Master, Associate chief physician, Department of Orthopaedics, Wuhan First Hospital (Wuhan Hospital of Integrated Traditional Chinese and Western Medicine), Wuhan 430022, Hubei Province, China
  • Supported by:
    2019-2020 Annual General Project of Hubei Provincial Health Commission, No. WJ2019F037 (to SJZ [project participant])

Abstract: BACKGROUND: SC79 is an Akt activator that has a certain cytoprotective effect. It cannot only inhibit excitotoxicity, but also reduce neuronal cell death caused by stroke.
OBJECTIVE: To investigate the mechanism of SC79 inhibiting dexamethasone-induced apoptosis and programmed necrosis of osteoblasts.
METHODS: Human osteoblasts, OB-6 cells, in logarithmic growth phase were divided into four groups: normal culture group, dexamethasone group treated with 2 μmol/L dexamethasone for 24 hours, SC79 group treated with 20 μmol/L SC79 for 24 hours, and SC79+dexamethasone group treated with 20 μmol/L 
SC79 for 2 hours and then 2 μmol/L dexamethasone for 24 hours. Cell activity, lactate dehydrogenase release, and apoptosis rate were detected. Activities of apoptosis-related factors Caspase-3, Bax, and Bcl-2, and the protein expression of oxidative stress-related factors cyclophilin D and cytochrome C were measured.
RESULTS AND CONCLUSION: Compared with the normal control group, the dexamethasone group significantly decreased cell activity (P < 0.05), increased lactate dehydrogenase release and mitochondrial membrane potential intensity (P < 0.05), elevated Caspase-3 and Bax activities and apoptosis rate (P < 0.05), decreased the expression of Bcl-2 protein (P < 0.05), and upregulated the expression levels of cyclophilin D and cytochrome C proteins (P < 0.05). Compared with the dexamethasone group, the SC79+dexamethasone group significantly increased cell activity (P < 0.05), reduced lactate dehydrogenase release and mitochondrial membrane potential intensity (P < 0.05), decreased Caspase-3 and Bax activities and apoptosis rate (P < 0.05), elevated the expression of Bcl-2 protein (P < 0.05), and downregulated the expression levels of cyclophilin D and cytochrome C proteins (P < 0.05). To conclude, SC79 can inhibit dexamethasone-induced apoptosis and programmed necrosis of osteoblasts by enhancing cell activity and inhibiting apoptosis, mitochondrial membrane potential and oxidative stress.

Key words: SC79, dexamethasone, osteoblast, apoptosis, programmed necrosis, mechanism

CLC Number: